Chloroquine reduces arylsulphatase B activity and increases chondroitin-4-sulphate: Implications for mechanisms of action and resistance

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Bhattacharyya, Sumit ^a,b   Solakyildirim, Kemal ^c   Zhang, Zhenqing ^c   Linhardt, Robert J ^c   Tobacman, Joanne K ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

^c Research Rensselaer Polytechnic Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLSULFATASE; ARYLSULPHATASE B; CHLOROQUINE; CHONDROITIN 4 SULFATE; GLYCOSAMINOGLYCAN; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; CHONDROITIN SULFATE; ENZYME INHIBITOR;

ANTIBIOTIC RESISTANCE; ARTICLE; BRAIN CELL; BRONCHUS MUCOSA; CONCENTRATION (PARAMETERS); DRUG EXPOSURE; DRUG MECHANISM; ENZYME ACTIVITY; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MASS SPECTROMETRY; PLACENTA; ANIMAL; CELL CULTURE; CHEMISTRY; CYTOSOL; DRUG ANTAGONISM; METHODOLOGY;

ANIMALS; ANTIMALARIALS; ARYLSULFATASES; CELLS, CULTURED; CHLOROQUINE; CHONDROITIN SULFATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOSOL; ENZYME INHIBITORS; HUMANS; MASS SPECTROMETRY;

EID: 76749112961     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-303     Document Type: Article

References (23)

1. Chondroitin sulfate A as an adherence receptor for Plasmodium falciparum-infected erythrocytes. SJ Rogerson GV Brown, Parasitol Today 1997 13 70 75 10.1016/S0169-4758(96)10081-8 15275126
2. Inhibition of binding of malaria-infected erythrocytes by a tetradecasaccharide fraction from chondroitin sulfate A. JG Beeson W Chai SJ Rogerson AM Lawson GV Brown, Infect Immun 1998 66 3397 3402 9632611
3. Chondroitin sulfate proteoglycan but not hyaluronic acid is the receptor for the adherence of Plasmodium falciparum-infected erythrocytes in human placenta, and infected red blood cell adherence up-regulates the receptor expression. A Muthusamy RN Achur M Valiyaveettil JJ Botti DW Taylor RF Leke DC Gowda, Am J Pathol 2007 170 1989 2000 10.2353/ajpath.2007.061238 17525266
4. Rat spongiotrophoblast-specific protein is predominantly a unique low sulfated chondroitin sulfate proteoglycan. RN Achur ST Agbor-Enoh DC Gowda, J Biol Chem 2006 281 32327 32334 10.1074/jbc.M605841200 16954212
5. Structural basis for binding of Plasmodium falciparum erythrocyte membrane protein 1 to chondroitin sulfate and placental tissue and the influence of protein polymorphisms on binding specificity. JG Beeson KT Andrews M Boyle MF Duffy EK Choong TJ Byrne JM Chesson AM Lawson W Chai, J Biol Chem 2007 282 22426 22436 10.1074/jbc.M700231200 17562715
6. Plasmodium falciparum: Chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta. M Fried GJ Domingo CD Gowda TK Mutabingwa PE Duffy, Exp Parasitol 2006 113 36 42 10.1016/j.exppara. 2005.12.003 16430888
7. Plasmodium falciparum: adherence of the parasite-infected erythrocytes to chondroitin sulfate proteoglycans bearing structurally distinct chondroitin sulfate chains. A Muthusamy RN Achur M Valiyaveettil DC Gowda, Exp Parasitol 2004 107 183 188 10.1016/j.exppara.2004.05.003 15363944
8. Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta. RN Achur M Valiyaveettil A Alkhalil CF Ockenhouse DC Gowda, J Biol Chem 2000 275 40344 40356 10.1074/jbc.M006398200 11005814
9. Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta. A Alkhalil RN Achur M Valiyaveettil CF Ockenhouse DC Gowda, J Biol Chem 2000 275 40357 40364 10.1074/jbc.M006399200 11005815
10. The low sulfated chondroitin sulfate proteoglycans of human placenta have sulfate group-clustered domains that can efficiently bind Plasmodium falciparum-infected erythrocytes. RN Achur M Valiyaveettil DC Gowda, J Biol Chem 2003 278 11705 11713 10.1074/jbc.M211015200 12517756
11. Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor. A Muthusamy RN Achur VP Bhavanandan GG Fouda DW Taylor DC Gowda, Am J Pathol 2004 164 2013 2025 15161637
12. Binding affinity of Plasmodium falciparum-infected erythrocytes from infected placentas and laboratory selected strains to chondroitin 4-sulfate. RN Achur A Muthusamy SV Madhunapantula DC Gowda, Mol Biochem Parasitol 2008 159 79 84 10.1016/j.molbiopara.2008.02.002 18359524
13. Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR. S Bhattacharyya JK Tobacman, Clin Chim Acta 2007 380 122 127 10.1016/j.cca.2007.01.021 17324393
14. Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates. S Bhattacharyya K Kotlo S Shukla RS Danziger JK Tobacman, J Biol Chem 2008 283 9523 9530 10.1074/jbc.M707967200 18285341
15. Cell-bound IL-8 increases in bronchial epithelial cells following arylsulfatase B silencing. S Bhattacharyya K Solakyildirim Z Zhang ML Chen RJ Linhardt JK Tobacman, Am J Respir Cell Mol Biol 19346317
16. Arylsulfatase B regulates colonic epithelial cell migration by effects on MMP9 expression and RhoA activation. S Bhattacharyya JK Tobacman, Clin Exp Metastasis 2009 26 535 545 10.1007/s10585-009-9253-z 19306108
17. Steroid sulfatase, arylsulfatases A and B, galactose 6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity. S Bhattacharyya JK Tobacman, J Steroid Biochem Mol Biol 2006 103 20 34 10.1016/j.jsbmb.2006.08.002 17064891
18. Quantification of heparan sulfate and heparin disaccharides using ion-pairing, reversed-phase, microflow, high performance liquid chromatography coupled with electrospray ionization trap mass spectrometry. Z Zhang J Xie H Liu J Liu RJ Linhardt, Anal Chem 2009 81 4349 4355 10.1021/ac9001707 19402671
19. Placental chondroitin sulfate A-binding malarial isolates evade innate phagocytic clearance. L Serghides SN Patel K Ayi KC Kain, J Infect Dis 2006 194 133 139 10.1086/504721 16741892
20. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. MF Duffy AG Maier TJ Byrne AJ Marty SR Elliott MT O'Neill PD Payne SJ Rogerson AF Cowman BS Crabb GV Brown, Mol Biochem Parasitol 2006 148 117 124 10.1016/j.molbiopara.2006.03.006 16631964
21. A ferriprotoporphyrin IX-chloroquine complex promotes membrane phospholipid peroxidation. Y Sugioka M Suzuki K Sugioka M Nakano, FEBS Letters 223 251 254 10.1016/0014-5793(87)80299-5 3666151
22. The basis of antimalarial action: non-weak base effects of chloroquine on acid vesicle pH. DJ Krogstad PH Schlesinger, Am J Trop Med Hyg 1987 36 213 210 2435182
23. Chemotherapy of Protozoal Infections: Malaria. TA Shapiro DE Goldberg, Goodman and Gillman's Pharmacological Basis of Therapeutics New York, NY, USA: McGraw-Hill Companies, Inc, Brunton LL, Lazo JS, Parker KL, 11 2008 Chaper 39 1021 1048